MyFinsight
Home
Blog
About
Contact
Download
Download image
Comprehensive loss
-$105,787,747
(-166.63%↓ Y/Y)
Net loss
-$105,043,946
(-159.58%↓ Y/Y)
Net unrealized gain
(loss) on marketable...
-$743,801
(-194.02%↓ Y/Y)
Investment income
$6,257,607
(184.05%↑ Y/Y)
Other income
$45,421
(507.96%↑ Y/Y)
Loss before income
taxes
-$105,042,346
(provision for) benefit
from income taxes
$1,600
Total other income
(expense)
$3,099,784
(47.77%↑ Y/Y)
Interest expense
$3,045,725
Loss on disposal of
fixed assets
-$157,519
(-39.64%↓ Y/Y)
Loss from operations
-$108,142,130
(-154.06%↓ Y/Y)
Total operating
expenses
$108,142,130
(66.80%↑ Y/Y)
Research and development
$84,454,595
(69.02%↑ Y/Y)
General and
administrative
$23,687,535
(59.33%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
CAPRICOR THERAPEUTICS, INC. (CAPR)
CAPRICOR THERAPEUTICS, INC. (CAPR)